Bacterial meningitis in the newborn: A prospective study of mortality and morbidity

Neonatal bacterial meningitis is a serious disease around the world, with the incidence changing little in the past 30 years. Group B streptococci, Esherichia coli, and Klebsiella pneumoniae are common causative organisms and lumbar puncture remains the definitive method of diagnosis. The mortality...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in perinatology 1999-06, Vol.23 (3), p.218-225
Main Authors: Harvey, David, Holt, Daphne E., Bedford, Helen
Format: Article
Language:English
Subjects:
Cephalosporins - therapeutic use
Escherichia coli Infections
Humans
Infant, Newborn
Klebsiella Infections
Klebsiella pneumoniae
Meningitis, Bacterial - diagnosis
Meningitis, Bacterial - drug therapy
Meningitis, Bacterial - mortality
Morbidity
Prospective Studies
Streptococcal Infections
Streptococcus agalactiae
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neonatal bacterial meningitis is a serious disease around the world, with the incidence changing little in the past 30 years. Group B streptococci, Esherichia coli, and Klebsiella pneumoniae are common causative organisms and lumbar puncture remains the definitive method of diagnosis. The mortality rate has declined in industrialized countries over the years, from almost 50% in the 1970s to less than 10% in 1997. However, neurological sequelae are still frequently observed despite major changes in treatment. Preliminary analysis of our own data from a prospective study of cases in the United Kingdom suggests that treatment with third generation cephalosporins is related to a decrease in mortality but not morbidity.
ISSN:0146-0005
1558-075X
DOI:10.1016/S0146-0005(99)80066-4